Comparative cytotoxicity of carmustine (BCNU), nimustine (ACNU) and elmustine (HeCNU) after depletion of O6-alkylguanine-DNA alkyltransferase (O6-AGT)

Anticancer Research

Volumn 22, Issue 2 A, 2002, Pages 697-701

  Buch T R ^a   Zeller, W J ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Carmustine; Elmustine; Nimustine; O6 alkylguanine DNA alkyltransferase; O6 benzyl guanine

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O BENZYLGUANINE; CARMUSTINE; ELMUSTINE; NIMUSTINE;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG POTENCY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; DRUG SYNERGISM; GUANINE; HUMANS; NIMUSTINE; NITROSOUREA COMPOUNDS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TUMOR CELLS, CULTURED;

EID: 0036244387     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Synthesis of potential anticancer agents. XXV. Preparation of 6-alkoxy-2-aminopurines
2. Inhibition of rat liver DNA polymerase by nitrosoureas and isocyanates
3. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding
4. 6-benzylguanine in vitro and in vivo
5. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents
6. 6-benzylguanine on the response to 1,3-bis(2-chloroethyl)-1-nitrosourea in the Dunning R3327G model of prostatic cancer
7. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)
8. 6-benzylguanine in humans: Metabolic, pharmacokinetic, and pharmacodynamic findings
9. DNA crosslinking and monoadduct repair in nitrosourea-treated human tumour cells
10. 6-benzylguanine for patients undergoing surgery for malignant glioma
11. 6-benzylguanine for patients with recurrent or progressive malignant glioma
12. Inhibition of the ligase step of excision repair by 2-chloroethyl isocyanate, a decomposition product of 1,3-bis(2-chloroethyl)-1-nitrosourea
13. 6-alkylguanine-DNA alkyltransferase activity in human myeloid cells
14. 6-benzylguanine plus BCNU
15. 6-methylguanine-DNA methyltransferase (MGMT) cDNA in Chinese hamster cells: The role of MGMT in protection against the genotoxic effects of alkylating agents
16. Inhibition of DNA repair by the 1,3-bis(2-chloroethyl)-1-nitrosourea breakdown product, 2-chloroethyl isocyanate
17. Primäre hirntumoren bei erwachsenen
18. 6-benzylguanine and sensitization to BCNU
19. 6-alkylguanine-DNA alkyltransferase
20. 6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea and on DNA interstrand cross-link formation
21. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
22. 6-methyguanine from DNA by human liver fractions
23. 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents
24. 6-methylguanine-DNA methyltransferase activity in breast and brain tumors
25. 6-Methylguanine-DNA Methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs
26. 6-benzylguanine followed by carmustine in patients with advanced cancer
27. 6-AGT plus chloroethylnitrosourea treatment - An experimental study
28. 6-alkylguanine-DNA-alkyltransferase
29. 6-alkylguanine-DNA-alkyltransferase and sensitivity to BCNU of human xenografts
30. 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis
31. More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat
32. Pronounced damage of intestinal tract mucosa by the combination of 1-methyl-1-nitrosourea plus 1,3-bis-(2-chloroethyl)-1-nitrosourea. Effect of drug sequence and time interval of administration